CVM
Cel-Sci Corp.

19,658
Mkt Cap
$73.22M
Volume
0.00
52W High
$32.70
52W Low
$1.98
PE Ratio
-0.93
CVM Fundamentals
50D MA
$9.75
Beta
0.99
Avg. Volume
187,265.19
EPS (Annual)
-$14.94
P/B
6.94
Loading...
Loading...
News
all
press releases
News Placeholder
Retail Buzz Builds Around Cel-Sci Stock Ahead Of Saudi Ruling On Cancer Drug Multikine
Multikine is a cancer immunotherapy, which has significantly improved survival in head and neck cancer patients during global Phase 3 trials.
Stocktwits·10d ago
News Placeholder
CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled
The formal agreement is expected to be signed with the Saudi pharmaceutical partner in the coming weeks, CEL-SCI said.
Stocktwits·4mo ago
News Placeholder
Cel-Sci Stock Slips After Public Offering: Retail's Neutral
The purchase price of each pre-funded Warrant is equal to the price per share of common stock being sold to the public in this offering, minus $0.01.
Stocktwits·10mo ago

Latest CVM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.